Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | AMPD2 | Q01433 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.46 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8818975 | 1.00 | MMP8 (0.48) | MMP8SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL28066882 | 1.00 | MMP8 (0.48) | MMP8SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL15124223 | 0.98 | MMP8 (0.47) | MMP8SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL11321868 | 0.98 | MMP8 (0.47) | MMP8SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL21357881 | 0.98 | MMP8 (0.47) | MMP8SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL9000765 | 0.98 | MMP8 (0.49) | MMP8SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL4206097 | 0.94 | MMP8 (0.50) | MMP8SMN1; SMN2NPC1GAATDP1 | |
| SCHEMBL11296489 | 0.89 | NPC1 (0.56) | SMN1; SMN2NPC1RAB9AALDH1A1POLB | |
| SCHEMBL3929627 | 0.89 | NPC1 (0.56) | SMN1; SMN2NPC1RAB9AALDH1A1POLB | |
| SCHEMBL27478078 | 0.89 | NPC1 (0.52) | SMN1; SMN2NPC1RAB9ATDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242544-A1 | Phytoactive Composition | MICAP PLC (GB) | 2008-10-02 | — | — | US | disclosed |
| US-20080140036-A1 | Antimicrobial Composition | MICAP PLC (GB) | 2008-06-12 | — | — | US | disclosed |
| US-20070269473-A1 | Microbial Encapsulation | MICAP PLC (GB) | 2007-11-22 | — | — | US | disclosed |
| EP-1753289-A1 | ANTIMICROBIAL COMPOSITION | MICAP PLC. (GB) | 2007-02-21 | — | — | EP | disclosed |
| EP-1750504-A1 | PHYTOACTIVE COMPOSITION | MICAP PLC. (GB) | 2007-02-14 | — | — | EP | disclosed |
| EP-1742728-A1 | MICROBIAL ENCAPSULATION | MICAP PLC. (GB) | 2007-01-17 | — | — | EP | disclosed |
| EP-1482806-B1 | TRANSESTERIFICATION REACTION FOR PRODUCTION OF DAIRY FLAVOUR ENHANCING ESTERS | FONTERRA CO OPERATIVE GROUP (NZ) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005104842-A1 | ANTIMICROBIAL COMPOSITION | MICAP PLC (GB) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005102508-A1 | MICROBIAL ENCAPSULATION | MICAP PLC (GB) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005102045-A1 | PHYTOACTIVE COMPOSITION | MICAP PLC (GB) | 2005-11-03 | — | — | WO | disclosed |
| US-20050130279-A1 | Transesterification reaction for production of dairy flavour enhancing esters | NEW ZEALAND DAIRY BOARD (NZ) | 2005-06-16 | — | — | US | disclosed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | disclosed |
| EP-1482806-A1 | TRANSESTERIFICATION REACTION FOR PRODUCTION OF DAIRY FLAVOUR ENHANCING ESTERS | Fonterra Co-Operative Group Limited (NZ) | 2004-12-08 | — | — | EP | disclosed |
| WO-2003070010-A1 | TRANSESTERIFICATION REACTION FOR PRODUCTION OF DAIRY FLAVOUR ENHANCING ESTERS | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2003-08-28 | — | — | WO | disclosed |
| US-5571925-A | HORMONES INHIBITORS FOR HYPOTENSIVE AGENTS | ELI LILLY AND COMPANY (US) | 1996-11-05 | — | — | US | disclosed |
| US-5563278-A | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1996-10-08 | — | — | US | disclosed |
| EP-0438869-B1 | Improvements in and relating to angiotensin II antagonists | LILLY CO ELI (US) | 1994-12-14 | — | — | EP | disclosed |
| US-5312936-A | Hypotensive agents | ELI LILLY AND COMPANY (US) | 1994-05-17 | — | — | US | disclosed |
| US-5073566-A | Hypotensive agents | ELI LILLY AND COMPANY (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0438869-A1 | Improvements in and relating to angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1991-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242544-A1 | Phytoactive Composition | PNMT, ACHE, TACR1 | MMP8 2707/4885SMN1; SMN2 4116/4885NPC1 1181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.